Redhill Biopharma (RDHL) Competitors $1.20 -0.11 (-8.40%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$1.28 +0.09 (+7.08%) As of 05:42 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock RDHL vs. ALLR, LPTX, NERV, EQ, ERNA, BFRG, ALVR, BIVI, FLGC, and MTVAShould you be buying Redhill Biopharma stock or one of its competitors? The main competitors of Redhill Biopharma include Allarity Therapeutics (ALLR), Leap Therapeutics (LPTX), Minerva Neurosciences (NERV), Equillium (EQ), Ernexa Therapeutics (ERNA), Bullfrog AI (BFRG), AlloVir (ALVR), BioVie (BIVI), Flora Growth (FLGC), and MetaVia (MTVA). These companies are all part of the "pharmaceutical products" industry. Redhill Biopharma vs. Its Competitors Allarity Therapeutics Leap Therapeutics Minerva Neurosciences Equillium Ernexa Therapeutics Bullfrog AI AlloVir BioVie Flora Growth MetaVia Redhill Biopharma (NASDAQ:RDHL) and Allarity Therapeutics (NASDAQ:ALLR) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, media sentiment, earnings, risk, analyst recommendations, dividends and valuation. Is RDHL or ALLR more profitable? Redhill Biopharma's return on equity of 0.00% beat Allarity Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Redhill BiopharmaN/A N/A N/A Allarity Therapeutics N/A -147.94%-90.33% Which has more risk & volatility, RDHL or ALLR? Redhill Biopharma has a beta of 4.18, suggesting that its stock price is 318% more volatile than the S&P 500. Comparatively, Allarity Therapeutics has a beta of 0.08, suggesting that its stock price is 92% less volatile than the S&P 500. Do insiders & institutionals believe in RDHL or ALLR? 7.2% of Redhill Biopharma shares are held by institutional investors. Comparatively, 11.5% of Allarity Therapeutics shares are held by institutional investors. 6.8% of Redhill Biopharma shares are held by company insiders. Comparatively, 0.0% of Allarity Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has higher earnings & valuation, RDHL or ALLR? Redhill Biopharma has higher revenue and earnings than Allarity Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRedhill Biopharma$8.04M0.34-$8.27MN/AN/AAllarity TherapeuticsN/AN/A-$24.51MN/AN/A Do analysts rate RDHL or ALLR? Allarity Therapeutics has a consensus target price of $9.00, indicating a potential upside of 791.09%. Given Allarity Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Allarity Therapeutics is more favorable than Redhill Biopharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Redhill Biopharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Allarity Therapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer RDHL or ALLR? In the previous week, Allarity Therapeutics had 8 more articles in the media than Redhill Biopharma. MarketBeat recorded 8 mentions for Allarity Therapeutics and 0 mentions for Redhill Biopharma. Allarity Therapeutics' average media sentiment score of 0.85 beat Redhill Biopharma's score of 0.00 indicating that Allarity Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment Redhill Biopharma Neutral Allarity Therapeutics Positive SummaryRedhill Biopharma and Allarity Therapeutics tied by winning 6 of the 12 factors compared between the two stocks. Get Redhill Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for RDHL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RDHL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RDHL vs. The Competition Export to ExcelMetricRedhill BiopharmaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.76M$2.50B$5.52B$9.35BDividend YieldN/A1.79%4.74%4.13%P/E RatioN/A8.9028.9723.78Price / Sales0.34693.47444.16183.69Price / CashN/A22.2824.4827.20Price / Book-0.334.838.375.61Net Income-$8.27M$31.61M$3.25B$265.26M7 Day Performance-26.38%-4.82%-3.55%-4.34%1 Month Performance-40.45%3.12%5.11%4.11%1 Year Performance-99.70%-2.00%25.37%17.92% Redhill Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RDHLRedhill BiopharmaN/A$1.20-8.4%N/A-99.7%$2.76M$8.04M0.00210ALLRAllarity Therapeutics2.9038 of 5 stars$1.12+9.8%$9.00+703.6%-79.1%$15.38MN/A0.0010Analyst DowngradeGap DownHigh Trading VolumeLPTXLeap Therapeutics1.8806 of 5 stars$0.34-5.6%$3.38+893.8%-85.1%$14.91MN/A-0.2040Upcoming EarningsGap DownNERVMinerva Neurosciences2.7571 of 5 stars$2.10-1.4%$5.00+138.1%-33.6%$14.90MN/A2.569Positive NewsUpcoming EarningsGap UpEQEquillium1.9474 of 5 stars$0.45+10.7%$3.00+573.2%+2.7%$14.38M$30.41M-1.1440Upcoming EarningsGap UpERNAErnexa Therapeutics0.8506 of 5 stars$1.91-2.1%N/A-94.2%$14.36M$580K-0.2310BFRGBullfrog AI0.781 of 5 stars$1.49-2.0%N/A-57.4%$14.31M$60K-1.844Upcoming EarningsALVRAlloVirN/A$2.76-2.8%N/A-84.8%$13.92MN/A-0.14110Upcoming EarningsHigh Trading VolumeBIVIBioVie0.1892 of 5 stars$7.10-5.1%N/A+67.5%$13.91MN/A-0.0910FLGCFlora Growth2.7678 of 5 stars$0.61-1.5%$4.00+560.2%-44.7%$13.89M$59.51M-0.62280Earnings ReportUpcoming EarningsGap DownMTVAMetaViaN/A$0.66-5.9%$7.50+1,030.4%N/A$13.81MN/A0.008 Related Companies and Tools Related Companies Allarity Therapeutics Competitors Leap Therapeutics Competitors Minerva Neurosciences Competitors Equillium Competitors Ernexa Therapeutics Competitors Bullfrog AI Competitors AlloVir Competitors BioVie Competitors Flora Growth Competitors MetaVia Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RDHL) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersWall Street Laughed. Now They're Buying.For six months, I’ve been pounding the table on a major gold miner—while Twitter pundits laughed. But now, the...Golden Portfolio | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Create New Advertiser | SponsoredTurn Trump's Market Boom into $5,917 Monthly ChecksHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredOut with the old (A.I.) - In with the new (E.I.)One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredStrange twist to Bitcoin’s rallyThe #1 crypto to buy today Better than Bitcoin? (top crypto for less than $1) Over the past 15 years, B...Stansberry Research | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Redhill Biopharma Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Redhill Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
